A Multi-Center, Randomized, Double-blind, Placebo-Controlled,Sequential Dose Escalation, Safety, Tolerability, and Preliminary Efficacy Study of MYOBLOC for the Treatment of Sialorrhea in Parkinson's Disease Patients
Latest Information Update: 13 May 2019
At a glance
- Drugs Botulinum toxin B (Primary)
- Indications Sialorrhoea
- Focus Therapeutic Use
- Sponsors US WorldMeds
Most Recent Events
- 13 May 2019 New trial record